CDC: Immunocompromised individuals may need FOURTH COVID-19 vaccine dose
By Mary Villareal // Nov 02, 2021

The Centers for Disease Control and Prevention (CDC) recently announced that individuals who are moderately or severely immunocompromised may need to get a fourth COVID-19 vaccine injection at least six months after their third dose.

Brighteon.TV

The CDC's new guidelines state that those who are moderately and severely immunocompromised should receive their third shot at least 28 days after their second dose and may follow up with a fourth dose after six months. "In such situations, people who are moderately and severely immunocompromised may receive a total of four COVID-19 vaccine doses," the CDC said.

Moderately to severely immunocompromised individuals refer to those who are in active cancer treatment for cancers of the blood or tumors. They also include organ transplant patients and stem cell recipients, people with advanced HIV and others who take high doses of corticosteroids or other immunosuppressants. (Related: Coronavirus booster shots: Boosting immunity or profits?)

The CDC believes that there are around 9 million immunocompromised individuals in the U.S. who qualify in these categories.

CDC recommends Pfizer-BioNTech or Moderna vaccines for immunocompromised

The CDC recommends immunocompromised individuals to be vaccinated with either the Pfizer-BioNTech or Moderna mRNA doses. However, the third shot is not considered a booster, but rather a part of their primary vaccination series.

Those with compromised immune systems do not mount adequate immune responses following the first two vaccinations, and the purpose of the third dose is to raise their immunity levels to what is usually seen in healthy individuals after two doses.

The fourth dose, on the other hand, is set to combat waning immunity and will serve the same purpose as a booster dose for those without immune system deficiencies six months after their initial vaccination.

"We know that six months after you reached a good level of protection, your protection has waned … and we need to boost that. That's for people with normal immune systems and people who are immunocompromised," said Dr. Dorry Segev, professor of surgery at Johns Hopkins University.

An estimated 2.7 percent of adults in the U.S. are considered immunocompromised, but not all of them will need a fourth dose.

The change in its clinical considerations comes less than a week after an advisory committee to the CDC officially endorsed a booster shot for the Moderna and J&J vaccines. The question of how and whether or not to provide a booster dose to immunocompromised individuals who may have already received their third dose was brought up during the advisory committee's meeting.

Dr. Doran Fink, the clinical deputy director of the division of vaccines and related products for the Food and Drug Administration (FDA), ??told the committee that under the emergency use authorization, someone who is immunocompromised and has received a third primary series dose would be eligible for the fourth dose six months later.

CDC spokesperson Kristen Norlund said that the clinical considerations were already updated as a result of the discussions.

While the decision is logical from a scientific standpoint, Dr. Balazs Halmos, director of thoracic oncology at the Montefiore Einstein Cancer Center in New York City, said that it is not necessarily data-driven.

Dr. Matt Kalaycio from the department of hematology and medical oncology at Cleveland Clinic agreed, saying that he is unaware of data supporting a fourth dose in immunocompromised patients. "It is unclear to me on which data the CDC is leaning to reach their conclusion," he said.

However, because the third dose for immunocompromised patients was just authorized in August, he believes that the recommended fourth shot is not imminent at the moment.

Get more COVID-19 vaccination updates at Pandemic.news.

Sources include:

InfoWars.com

NBCNews.com



Take Action:
Support NewsTarget by linking to this article from your website.
Permalink to this article:
Copy
Embed article link:
Copy
Reprinting this article:
Non-commercial use is permitted with credit to NewsTarget.com (including a clickable link).
Please contact us for more information.
Free Email Alerts
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.

NewsTarget.com © 2022 All Rights Reserved. All content posted on this site is commentary or opinion and is protected under Free Speech. NewsTarget.com is not responsible for content written by contributing authors. The information on this site is provided for educational and entertainment purposes only. It is not intended as a substitute for professional advice of any kind. NewsTarget.com assumes no responsibility for the use or misuse of this material. Your use of this website indicates your agreement to these terms and those published on this site. All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.

This site uses cookies
News Target uses cookies to improve your experience on our site. By using this site, you agree to our privacy policy.
Learn More
Close
Get 100% real, uncensored news delivered straight to your inbox
You can unsubscribe at any time. Your email privacy is completely protected.